SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Pre-Close Trading Update

24 Jul 2025 07:00

RNS Number : 2827S
City of London Investment Group PLC
24 July 2025
 

City of London Investment Group PLC

24 July 2025

 

 

CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group" or "the Company" or "CLIG")

PRE-CLOSE TRADING UPDATE FOR THE YEAR ENDED 30 JUNE 2025

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds ("CEFs"), provides a pre-close trading update for its financial year ended 30 June 2025. The numbers that follow are unaudited.

 

Funds under Management (FuM) increased by 5.6% to $10.8 billion as of 30 June 2025 as compared to $10.2 billion as of 30 June 2024. 

 

Investment Management Performance

It was broadly a favourable environment for CLIM's investment strategies from a performance perspective and all strategies ended the year ahead of their benchmarks as the table below demonstrates.

 

CLIM strategy

Performance

Benchmark

Difference

Emerging Markets

+20.3%

+14.8%

+550bps

International Equity

+22.7%

+17.7%

+500bps

Opportunistic Value

+17.5%

+12.8%

+470bps

Listed Private Equity

+16.6%

+8.0%

+860bps

\* The above returns are presented as net of fees performance figures. The CLIM Global Emerging Markets strategy is shown against the S&P Emerging Frontier Super Composite BMI Net TR Index, the CLIM Global Developed CEF International Equity Strategy is shown against the MSCI ACWI ex-US Net TR Index, the CLIM Opportunistic Value Strategy is shown against the Blended 50/50 MSCI AWCI/Bloomberg Global Aggregate Bond Index, and the CLIM Listed Private Equity Strategy is compared to an 8% annual hurdle rate. Data is as of 30 June 2025. Past performance is no guarantee of future results.

 

Firstly, our strategies have benefited from an improved environment for corporate governance. The last few years since 2022 have been characterised by a period of wide discounts among the universe of closed-end funds in which CLIM primarily sources investments. This has been particularly pronounced in the UK market where outflows from institutional and retail investors alike had resulted in depressed ratings. Such ratings allowed CLIM to accumulate positions at deeply valued price points and to work with boards to take measures to address discounts. Among other factors, these engagements helped provide the catalyst for broad-based actions by boards to narrow discounts on funds held in portfolios. Such event-driven actions included elevated levels of share buybacks, tender offers, mergers, restructurings and, in extreme cases, outright liquidations. CLIM's strategies benefited accordingly.

 

Secondly, heightened market volatility, particularly since the election of President Trump in late 2024, has provided additional opportunities to benefit from discount volatility, as well as market rotation, as countries, sectors, size and style factors came in and out of favour.

 

Lastly, outperformance by non-US equities over the last twelve months, after more than a decade of dominance by US stocks, brought new buyers to our largest areas of underlying focus, namely International Equities and Emerging Markets.

 

The International Equity strategy benefited from increased demand, especially for European and UK large cap exposure as well as International mid and small cap exposure.

Conversely, in addition to the factors highlighted above, the Emerging Markets strategy was meaningfully aided by its allocation to South Korean holding companies which outperformed following the Government's proposed Corporate Value Up program designed to address the "Korea Discount" by promoting capital efficiency, transparent governance and increased shareholder returns.

 

Likewise, KIM's main strategies performed well over the trailing twelve months.

 

KIM strategy

Performance

Benchmark

Difference

Growth Balanced

+12.71%

+12.16%

+55bps

Conservative Balanced

+9.2%

+10.07%

-87bps

Tax-Sensitive Fixed Income

+3.17%

+1.10%

+207bps

Taxable Fixed Income

+7.39%

+5.89%

+150bps

Cash Management

+5.96%

+5.67%

+29bps

Equities

+16.80%

+16.33%

+46bps

\* The KIM Fixed Income Strategy is shown against the Bloomberg Government/Credit Bond Index, the KIM Tax-Sensitive Fixed Income Strategy is shown against the Bloomberg Municipal Bond Index, the KIM Growth Balanced Strategy is shown against the Blended 40% Bloomberg Government/Credit Bond Index/39% Russell 3000 Index/21% MSCI ACWI ex USA Net TR Index. The KIM Conservative Balanced Strategy is shown against the Blended 60% Bloomberg Government/Credit Bond Index/26% Russell 3000 Index/14% MSCI ACWI ex USA Net TR Index. The KIM Equities Strategy is shown against the Blended 65% Russell 3000 Index/35% MSCI ACWI ex USA Net TR Index. The KIM Cash Management Strategy is shown against the ICE BofA 1-3 Year US Treasury Index.

 

The primary contributor to outperformance over the past twelve months has been a modest narrowing of discounts across fixed income and equity closed-end funds. Performance was further enhanced by substantial tender offers executed near net asset value and notable distribution increases among several major holdings.

 

Special Purpose Acquisition Companies, during their pre-acquisition phase, continue to serve as effective alternatives to T-bills and money market funds within our Cash Management and Fixed Income strategies. While short-term performance remains important, KIM's long-term track record is particularly strong, especially in fixed income. Over the past five years, the Taxable Fixed Income and Tax-Sensitive Fixed Income strategies have exceeded their respective benchmarks by 6.60% and 3.67% per annum.

 

Flows

Net outflows were weighted more heavily to the first half of the financial year when macroeconomic uncertainty rattled markets. The second half withdrawals were characterised by some profit-taking after very strong performance by our investment teams. This was particularly true in the International Equity and Emerging Markets strategies which saw net outflows of $387 million and $372 million, respectively. The Growth and Conservative Balanced strategies (a combination of equity and fixed income) saw net outflows of $241 million over this period, due primarily to client retirement cash needs. Net investment outflows totaled $974 million across the Group during the financial year.

 

New mandates included $60 million in the Listed Private Equity strategy and $70 million in the Emerging Markets strategy, with another $46 million mandate confirmed for August 2025 funding. Net inflows of circa $84 million combined across the Opportunistic Value, Listed Private Equity, alternatives and Taxable Fixed Income strategies were also recorded.

 

Persistent discount volatility and strong outperformance of the Group's strategies continue to be the focus of marketing efforts with allocators.

 

A breakdown FuM by strategy is as follows:

 

 

 

FuM ($ million)

Jun-24 Actual

 

Inflows

Outflows

Net Flows

Market & investment performance

Jun-25 (estimate)

 

CLIM

 

 

 

 

 

 

 

Emerging Markets

3,394

91

(463)

(372)

652

3,674

 

International Equity

2,394

122

(509)

(387)

479

2,486

 

Opportunistic Value

251

26

-

26

32

309

 

Listed Private Equity*

174

60

(50)

10

34

218

 

Other**

104

40

-

40

6

150

 

 

6,317

339

(1,022)

(683)

1,203

6,837

 

KIM***

 

 

 

 

 

 

 

Growth Balanced

1,426

36

(174)

(138)

131

1,419

 

Conservative Balanced

1,103

45

(148)

(103)

143

1,143

 

Tax-Sensitive Fixed Income

693

87

(108)

(21)

(144)

528

 

Taxable Fixed Income

501

58

(50)

8

198

707

 

Cash Management

108

10

(24)

(14)

7

101

 

Equities

93

3

(26)

(23)

9

79

 

 

3,924

239

(530)

(291)

344

3,977

 

 

10,241

578

(1,552)

(974)

1,547

10,814

 

* The Listed Private Equity strategy is to buy high quality private equity funds at discounts in closed-end fund structures traded in listed markets. It was recategorised from Emerging Markets during the year, and the recategorization of existing client assets is not reflected in the Net Flows column for either strategy.

** Includes Frontier and alternatives

*** KIM's FuM has been recategorised into underlying strategies.

Funds under Management figures are rounded

 

Leadership Update

In June, Mike Edmonds was appointed Chief Investment Officer of CLIM. A highly accomplished investor and City of London veteran, Mike first began his career with the Group in 1992. He brings deep investment expertise, creativity, and an engaging intellectual curiosity-qualities that complement his strong collaborative relationships across our Investment, Research, and Macroeconomic teams.In his capacity as Chairman, Rian Dartnell continues to work closely with our teams and with the Board to evaluate CEO candidates and consider the Group's future leadership needs. A further announcement will be made in due course. Meanwhile, our entire team is focused on providing strong risk-adjusted returns, enhancing client service excellence, and deepening shareholder engagement. We are also reinforcing our commitment to inclusivity and accountability to position the Group for long-term success.

 

 

Dividend

The Board expects the final dividend for the year ended 30 June 2025 to be in line with the previous year.

 

Following the completion of the year-end audit, the Board will announce the final dividend and results alongside publication of its Accounts for the year ended 30 June 2025 on 16 September 2025.

 

The Group's Annual General Meeting will be held on 27 October 2025 and the Group expects the dividend payment date to be in November 2025 similar to last year's timing.

 

For further information, please visit https://www.clig.com/ or contact:

 

Rian Dartnell, Chairman

City of London Investment Group PLC

Tel: 001-203-561-0450

 

Martin Green, James Hornigold, Louisa Waddell

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

 

This release includes forward-looking statements, which may differ from actual results. Any forward-looking statements are based on certain factors and assumptions, which may prove incorrect, and are subject to risks, uncertainties and assumptions relating to future events, the Group's operations, results of operations, growth strategy and liquidity.

 

Past performance is no guarantee of future results.

The information contained in this document is intended for infor-mation purposes only. This document does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will any sale of a security occur in any jurisdiction where such an offer, solicitation or sale would be unlawful.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEAFDDEISEFW
Date   Source Headline
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE
23rd May 20244:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.